OMB Is Rewriting the Rules of Every Federal Grant: Inside the 2 CFR Part 200 Overhaul, the July 13 Comment Deadline, and the October 1 Effective Date

For most of its life, 2 CFR Part 200 — the "Uniform Guidance" — has been the quiet plumbing of the federal grant system. It sets the cost principles, audit thresholds, and administrative requirements that every recipient of federal money learns to live with. Grant managers cite it; almost no one outside the profession has ever heard of it. That is about to change.

On May 29, 2026, the Office of Management and Budget, joined by more than 40 federal grantmaking agencies, formally opened a rulemaking to rewrite Part 200 and rebrand it the "Uniform Grants Regulation." The comment period closes July 13, 2026, and OMB has proposed a final rule effective October 1, 2026 — the first day of fiscal year 2027. That is an aggressive timeline for a document that touches every university, hospital, nonprofit, tribe, and state and local government that accepts federal financial assistance.

This is not a routine refresh. The proposal changes both what the rules say and what kind of thing the rules are. Below is what is actually in it, and what recipients should do between now and the fall.

From "guidance" to "regulation" — the change hiding in the title

The most consequential edit is the one easiest to skim past. Today, Part 200 is styled as guidance that agencies adopt into their own regulations. The proposal reclassifies it as a binding regulation with direct legal force under the Administrative Procedure Act.

That reclassification is the load-bearing wall for everything else. Guidance is interpretive and gives agencies room to maneuver; a codified regulation is enforceable on its own terms and harder to waive at the program level. Once the document is binding, every prohibition, screening requirement, and termination trigger inside it becomes a compliance obligation rather than a best practice. If you read only one structural change, read this one — it is what gives the rest of the rule its teeth.

Political review moves to the front of the line

The proposed rule introduces a mandatory pre-award review in which senior political appointees must confirm that a proposed award aligns with "applicable law, agency priorities, and the national interest." Peer and merit review — the scientific and programmatic evaluation that has historically decided awards — becomes advisory rather than determinative.

This is not hypothetical. In a July 2 House Appropriations hearing, Rep. Rosa DeLauro pointed to what she described as OMB already implementing political review, citing "massive delays" at NSF and a roughly 34% decrease in new NIH awards in 2026 compared with prior years. Rep. Marie Gluesenkamp Perez pressed OMB Director Russ Vought on whether the process affords due process and raised concerns about AI tools being used to flag grants as inconsistent with administration priorities.

For applicants, the practical takeaway is timing risk. Even a technically excellent, peer-endorsed proposal can now sit behind an appointee-level review with no fixed clock. Build longer award-decision windows into your cash-flow planning, and do not assume a strong score means a fast — or certain — award.

The termination language is the part to read twice

If reclassification is the structural story, termination authority is the operational one. The proposal gives agencies a new discretionary right to terminate an award when it "no longer effectuates program goals or agency priorities," plus a 90-day temporary suspension authority that can be invoked without cause. These powers apply to discretionary awards unless a statute says otherwise.

Here is the sharp edge: for discretionary "national interest" terminations, the rule does not guarantee objection or appeal rights. Formal due-process protections attach to noncompliance-based terminations — but a priorities-based termination sits in a different bucket. In plain terms, an award you are executing flawlessly could still be ended mid-stream if agency priorities shift, and your procedural recourse may be limited.

That single asymmetry should reshape how organizations think about federal dependence. It raises the value of diversified funding, milestone-based drawdowns, and contract language that anticipates early termination. If your operating model assumes multi-year federal awards run to completion, this is the clause that breaks the assumption.

The prohibited-purpose list

The rule codifies a set of funding prohibitions that, taken together, redraw the boundaries of allowable activity. Federal funds could not support:

• Diversity, equity, and inclusion (DEI) initiatives
• "Gender ideology," defined in the proposal as denying biological sex or the sex binary, and sex-transition services for minors (the proposal references those under 19)
• Abortion-related costs unless expressly authorized
• Expanded lobbying and advocacy — the definition is broadened to reach issue advocacy and voter registration

Cost-principle changes accompany the list: fixed-amount awards are eliminated except where statutorily authorized, advertising and public-relations costs become largely unallowable, conference attendance requires express agency approval, and fundraising or investment costs need prior written approval. Organizations that have leaned on fixed-amount awards for administrative simplicity will need to rebuild those budgets around actual-cost reporting.

Compliance mechanics: E-Verify, Do Not Pay, and faster fraud reporting

Beyond the headline prohibitions, the rule layers on new administrative machinery:

• Mandatory E-Verify for all employees and contractors working on a federal award
• Pre-payment screening through Treasury's "Do Not Pay" system
• Inspector General fraud reporting within 10 days
• Enhanced conflict-of-interest disclosure, cybersecurity, and data-safeguarding requirements

None of these is exotic on its own, but collectively they raise the fixed cost of holding a federal award — which lands hardest on smaller nonprofits without dedicated compliance staff.

Foreign collaboration and the "U.S.-entities-only" default

The proposal restricts R&D awards to U.S.-based entities and prohibits collaboration with "covered foreign countries" and foreign entities absent an agency-head waiver. It also requires federal award documents to be in English unless otherwise authorized. Research universities and global-health nonprofits should inventory every international subaward and partnership now; some long-standing collaborations may require a waiver that does not yet have a clear process.

What did not change

One notable non-change: the proposal does not alter indirect cost rate negotiation. FY2026 appropriations language prohibits modifications, so the current negotiated-rate system stands — though OMB signals possible future action. If you were bracing for a cut to indirect recovery, that fight has been deferred, not resolved.

The legal cloud overhead

This rule is contested. All Senate Democrats signed a July 1 letter arguing OMB lacks statutory authority to issue binding grant regulations, that the proposal undermines Congress's power of the purse, and that it could let the executive "weaponize" grants for political ends. OMB reported more than 3,600 comments received within days of the hearing. Litigation over the final rule is widely expected. That means the October 1 effective date is a planning assumption, not a certainty — but planning as if it will take effect is the prudent posture.

A preparation checklist for the next 90 days

1. Comment by July 13. Specific, institution-level comments about implementation ambiguity carry more weight than general opposition. Point to concrete operational conflicts in your award portfolio.
2. Inventory exposure. Flag active awards with DEI language, international partnerships, fixed-amount structures, or advocacy-adjacent activities.
3. Audit subaward reporting on SAM.gov — unreported subawards are an enumerated noncompliance termination trigger.
4. Stand up E-Verify if you are not already enrolled, and map which staff and contractors it will cover.
5. Rewrite the termination assumptions in your budgets and board reporting. Model a scenario where a discretionary award ends at 90 days' notice.
6. Diversify. The clearest strategic response to concentrated termination risk is a funding base that is not majority-federal. Private foundations, state programs, and earned revenue all become more valuable when federal awards carry new discretionary fragility. Granted's funder search can help map non-federal alternatives aligned to your mission.

The Uniform Guidance spent a decade as invisible infrastructure. The proposed Uniform Grants Regulation makes it a live strategic variable — one that every serious grant-seeking organization should be reading, commenting on, and planning around before October 1.